Skip to content

January 2026

Default mode network

What January 2026's 6 new studies found, synthesized from the papers below. All Default mode network research →

The synthesis

Synthesized from 6 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for Default mode network, DMN, resting-state network, then ranked by relevance.

Research in January 2026 consistently identifies the default mode network (DMN) as a key neural substrate in psychedelic therapy, hypnosis, and psychiatric disorders, with findings showing that psychedelics like psilocybin reduce DMN activity and rigidity, correlating with therapeutic benefits. However, the evidence is largely from reviews and theoretical frameworks rather than new empirical studies, and one study on multiple sclerosis suggests DMN disruption may also occur in non-psychedelic contexts, indicating the DMN's role is complex and not fully understood.

Confidence in the evidence

Low-Moderate
  • The evidence consists of 5 relevant studies, all of which are reviews or theoretical articles with no new empirical data from January 2026.
  • No RCTs or original neuroimaging studies from January 2026 are included; the findings are based on synthesis of prior research.
  • The studies consistently point to DMN modulation in psychedelic and hypnotic contexts, but the direction and magnitude of effects are not quantified in the provided abstracts.
  • One study on multiple sclerosis introduces a potential confound, showing DMN disruption in a non-psychedelic condition, which limits the specificity of conclusions.
How we rate confidence

Confidence reflects the strength of the underlying evidence, not whether the result is favorable. It weighs the number and size of studies, their design (randomized trials count for more than observational or single-case work), how consistently they point the same way, and their risk of bias.

Tiers run from Insufficient to High. High is rare in this field: small, early, or open-label studies land lower even when their direction is encouraging.

Evidence by study

Direction is each study's finding relative to your question: Supports, Opposes, No effect, Mixed, or Unclear.

Hypnosis as a Mechanism of Emotion Regulation and Self-Integration: Neural, Cognitive, and Experiential Pathways to Fundamental Peace 2026
Supports

Hypnosis modulates the default mode network (DMN) along with other networks to reorganize emotional experience and self-referential processing.

review

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence 2026
Supports

Psilocybin reduces DMN activity and connectivity, contributing to rapid and sustained antidepressant effects.

review

THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026
Supports

Psilocybin and LSD cause disintegration of the DMN, which correlates with alleviation of rigid cognitive patterns in depression and anxiety.

systematic review

Altered excitation-inhibition balance in the somatomotor and default mode network in multiple sclerosis 2026
Unclear

Altered excitation-inhibition balance is observed in the DMN in multiple sclerosis, but the direction of effect on DMN function is not specified.

observational

The Experiential Self State as Affective Salience: Neurobiological, embodied, and predictive foundations of non-reflective consciousness 2026
Supports

The reflective self, underpinned by DMN activity, is contrasted with an experiential self state, and altered states like meditation can shift away from DMN-dominated processing.

theoretical

A Randomized Controlled Trial of Psilocybin for the Treatment of Obsessive-Compulsive Disorder 2026
Supports

OCD is associated with a hyperfunctioning DMN, and psilocybin may break rigid neuronal patterns by modulating the DMN.

review

Points of agreement

  • Psychedelics (psilocybin, LSD) reduce DMN activity and connectivity, which is linked to therapeutic effects in depression, anxiety, and OCD.
  • Hypnosis and meditation also modulate the DMN, suggesting a common pathway for altering self-referential processing.
  • DMN dysfunction is implicated in multiple psychiatric and neurological conditions, including OCD and multiple sclerosis.

Conflicts

  • One study on multiple sclerosis reports altered DMN excitation-inhibition balance, but the direction (whether increased or decreased DMN activity) is unclear, contrasting with the consistent reduction seen in psychedelic studies.
  • The theoretical framework in one study distinguishes between reflective (DMN-based) and experiential self states, but other studies do not explicitly adopt this dual-self model.

Gaps

  • No new empirical neuroimaging data from January 2026 are provided; all studies are reviews or theoretical.
  • The durability of DMN changes beyond the acute psychedelic experience is not addressed in the provided abstracts.
  • Sample sizes and specific populations are not reported for most studies, limiting generalizability.
  • The relationship between DMN modulation and clinical outcomes is correlational, not causal, in the reviewed evidence.
Browse these studies in the library